Navigation Links
Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
Date:2/25/2008

New GeneXpert(R)-Based Test to Assess Genetic Risk of Thrombosis Improves Time to Result and Eliminates Delays Associated with Batch Processing

SUNNYVALE, Calif., and LEXINGTON, Mass., Feb. 25 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) and Instrumentation Laboratory (IL), a leading clinical diagnostics company, today announced the release of the Xpert (TM) HemosIL(R) FII & FV assay as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices. Delivering results in just over thirty minutes with a single GeneXpert(R) cartridge, the Xpert HemosIL FII & FV assay detects Factor II (FII) and Factor V Leiden (FV) genetic variations associated with thrombophilia, an increased risk of blood clots (thrombosis). Developed and manufactured by Cepheid, the test is expected to be available for sale beginning March 4th through IL, the exclusive worldwide distributor for the Xpert HemosIL FII & FV assay.

Xpert HemosIL FII & FV is the first test to be commercialized under the exclusive development and distribution agreement for hemostasis molecular diagnostic tests, entered into by IL and Cepheid in April 2007.

"Given the complexity of traditional molecular diagnostics, clinical laboratories currently may wait up to a week for FII and FV genotyping. The Xpert HemosIL FII & FV assay will allow laboratories to perform the test as needed -- and integrate the results with other tests -- providing physicians a comprehensive thrombophilia profile of their patients," said Cepheid Chief Executive Officer John Bishop. "Given the strength of its HemosIL line of hemostasis assays, IL is the ideal partner for the distribution of this and potentially other important tests for the hemostasis laboratory
'/>"/>

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
2. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
3. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
4. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
5. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
6. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
7. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
8. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
9. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
10. Instrumentation Laboratory Receives FDA Clearance to Expand the Intended Use for HemosIL(R) D-Dimer HS Assay
11. Thermo Fisher Scientific Selected by China Doping Control Center to Supply Testing Instrumentation for the 2008 Olympic Games in Beijing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... TORONTO , Sept. 22, 2014 ... (OTCBB:GNBT) today announced that it has entered into ... to which UHN,s Centre for Molecular Design and ... refinement project.  The goal of the project is ... the Company,s proprietary buccal insulin spray product, thereby ...
(Date:9/22/2014)... 22, 2014 FierceBiotech today announced its ... biotechnology companies of 2014. FierceBiotech editors John Carroll ... this year’s winners. Those selected are identified as ... the industry. , "It's always a lot ... Fierce 15 companies," said Carroll. "This year in particular ...
(Date:9/22/2014)... The US markets on Friday, ... the Dow Jones Industrial Average finished at 17,279.74, up ... 0.30%. The S&P 500 finished the session 0.05% lower ... ten sectors finished on a positive note. The S&P ... 751.48, up 0.10%, with the index gaining 6.95% in ...
(Date:9/22/2014)... , Sept. 22, 2014 ... GEVA ), a biopharmaceutical company developing therapeutic products ... Robert Bazemore as Chief Operating Officer.  ... President and Chief Executive Officer, Robert will oversee ... lead program, sebelipase alfa for LAL Deficiency, and ...
Breaking Biology Technology:Generex Collaborates with University Health Network for Buccal Insulin Project 2Generex Collaborates with University Health Network for Buccal Insulin Project 3Generex Collaborates with University Health Network for Buccal Insulin Project 4FierceBiotech Announces Annual “Fierce 15” Winners of 2014 2Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 2Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 3Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 4Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma 5Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 2Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 3Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 4
... Students, faculty and supporters of The University of Texas ... state-of-the-art Engineering Research Building with a March 4 dedication ... ) The landmark center is UT ... by College of Engineering and College ...
... PITTSBURGH, March 1, 2011 D3 Oncology Solutions ... Via Oncology Pathways for medical oncology to the ... D3 now offers integrated pathways programs to both ... Via Oncology Pathways are evidence-based clinical algorithms that ...
... 2011 Iverson Genetic Diagnostics, Inc. announced today that the ... R eduction f or A dults R ... at WellStar Health System in Marietta and other major hospital ... determine a personalized warfarin dose for individual patients to reduce ...
Cached Biology Technology:UT Arlington Honors Collaborative Research During March 4 Engineering Research Building Dedication 2UT Arlington Honors Collaborative Research During March 4 Engineering Research Building Dedication 3D3 Oncology Solutions Now Includes Via Oncology Pathways for Medical Oncology 2WARFARIN Study Launched at WellStar Health System to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin 2WARFARIN Study Launched at WellStar Health System to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin 3WARFARIN Study Launched at WellStar Health System to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin 4
(Date:9/22/2014)... 22, 2014Cassava, also known as tapioca, has large starch-filled ... of Africa, Asia, and Latin America where corn and ... novel enzymes and processes designed to break down tapioca ... produce sweeteners such as glucose, fructose, or maltose syrup, ... described in a Review article in Industrial Biotechnology ...
(Date:9/22/2014)... institutions in the country selected by the National ... BEST Award a $2 million grant designed ... biomedical sciences graduate trainees to career opportunities that ... traditionally taken. , The award funds development of ... (iJOBs) program. It includes courses, seminars, shadowing, mentoring ...
(Date:9/22/2014)... in the wake of the huge King Fire blazing ... The King Fire is burning in steep terrain in ... Creek Canyon, and the Rubicon Canyon, north of the ... Placer County and burned onto the Tahoe National Forest ... is expected to be minimal on Sept. 22 due ...
Breaking Biology News(10 mins):Rutgers receives $2 million grant to prepare biomedical students for roles in industry 2Rutgers receives $2 million grant to prepare biomedical students for roles in industry 3
... good chance that forest fires in the Pacific Northwest will ... expert speaking today at a professional conference, that,s just fine. ... to predict, will always be variable, and undoubtedly a part ... is not only inevitable but also a valuable part of ...
... feet were built the same way as a mongoose,s feet, they,d ... support the big cat,s weight. But they,re not. For decades, ... put together across the four-legged animal kingdom, but until now they ... foot that bear the brunt of the animal,s walking and running. ...
... particles called neutrons are poised to play a big ... manufacturing processes. The reason: They are the focus of ... to study the chemistry of a wide range of ... a fascinating article in Chemical & Engineering News ...
Cached Biology News:More frequent fires could aid ecosystems 2More frequent fires could aid ecosystems 3The bigger the animal, the stiffer the 'shoes' 2
... Blot Processing mini Tray (3 per ... gel staining and blot processing.Automated staining ... for proteins and nucleic acid analysis.Prepares ... and chromogenic detection.Programmable control of protocol, ...
L1 Protein of Human Papilloma Virus Purified Anti-Viral-transformed cells clone CAMVIR-1, Isotype Mouse IgG 2a , 0.1 mg Consult technical datasheet for details....
... 1 g. High quality kits ... preparation that give consistent and ... and tissues.Clean up samples from ... Accurately quantitate protein for first-dimension ...
... Varian Cary 50 Microplate Reader ... cost per analysis by extending ... the award-winning Cary 50 instruments. ... to 384 samples in microlitre ...
Biology Products: